Skip to content

Clinical trials

Non-ST Elevated Myocardial Infarction trials in China

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Non-ST Elevated Myocardial Infarction Country / region: China Clear all

15 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20122
20131
20163
20173
20181
20201
20211
20241
20252

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Unknown status9
Completed4
Not yet recruiting1
Recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Novartis Pharmaceuticals2
BIOTRONIK Asia Pacific Pte Ltd1
Beijing Anzhen Hospital1
Beijing Luhe Hospital1
Central South University1
China National Center for Cardiovascular Diseases1
Chinese Academy of Medical Sciences, Fuwai Hospital1
First Affiliated Hospital of Xinjiang Medical University1
Harbin Medical University1
Henan Provincial People's Hospital1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Non-ST Elevated Myocardial Infarction15
ST Elevation Myocardial Infarction6
Acute Coronary Syndrome2
Angina, Unstable2
Coronary Artery Disease2
Myocardial Ischemia2
Angina Pectoris1
Angina, Stable1
Cardiovascular Diseases1
Diabetes Mellitus, Type 11

Trials

Showing 76 to 15 of 15. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.